Double-blind Study in Paediatric Epileptic to Compare the Subject Preference for ESL Suspension Formulation With Alternative Flavours
NCT02021461 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 38
Last updated 2014-04-03
Summary
The purpose of this study is to investigate the taste preference in children of 3 different flavours of the ESL oral suspension.
Conditions
Interventions
- DRUG
-
ESL Banana taste
oral suspension with Banana flavor at a concentration of 50 mg/mL and was administered in 2.5 mL doses.
- DRUG
-
ESL Grape taste
oral suspension with Grape flavor at a concentration of 50 mg/mL and was administered in 2.5 mL doses.
- DRUG
-
ESL Tutti-Frutti taste
oral suspension with Tutti-Frutti flavor at a concentration of 50 mg/mL and was administered in 2.5 mL doses.
Sponsors & Collaborators
-
Bial - Portela C S.A.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 5 Years
- Max Age
- 8 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- Romania
- Slovakia
Study Locations
More Related Trials
-
A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment
NCT04627285 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures
NCT00957684 ·Status: COMPLETED ·Phase: PHASE3
-
Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children
NCT00988156 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy
NCT00957372 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)
NCT00566254 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures
NCT02477839 ·Status: COMPLETED ·Phase: PHASE3
-
Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)
NCT01532726 ·Status: COMPLETED
-
A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures
NCT01964560 ·Status: COMPLETED ·Phase: PHASE3
-
Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures
NCT02484001 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).
NCT04721691 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU
NCT01999777 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters
NCT01390220 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures
NCT02408549 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
NCT02408523 ·Status: COMPLETED ·Phase: PHASE3
-
Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate
NCT02288312 ·Status: COMPLETED ·Phase: PHASE1
-
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures
NCT00520741 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test the Blood Concentration of 4 Padsevonil Product Variants and the Effect of Food on Padsevonil
NCT04283136 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effect of Sulthiame on EEG in Childhood Epilepsy Syndromes
NCT05885646 ·Status: RECRUITING
-
A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)
NCT01830400 ·Status: COMPLETED
-
Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy
NCT00693017 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers
NCT02777671 ·Status: COMPLETED ·Phase: PHASE1
-
Anti-epileptogenic Effects of Eslicarbazepine Acetate
NCT06597084 ·Status: COMPLETED ·Phase: PHASE2
-
Pediatric Epilepsy Trial in Subjects 1-24 Months
NCT00043875 ·Status: COMPLETED ·Phase: PHASE2
-
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
NCT00422422 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures
NCT00437281 ·Status: COMPLETED ·Phase: PHASE1/PHASE2